Clinical Trials Logo

EphA2 Positive Malignant Glioma clinical trials

View clinical trials related to EphA2 Positive Malignant Glioma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02575261 Withdrawn - Clinical trials for CAR-T Cell Immunotherapy

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Start date: September 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with EphA2 positive malignant glioma patients.